Johnson & Johnson Needs Time To Consolidate (Technical Analysis And Downgrade)
Johnson & Johnson's long-term prospects are promising due to strong drug pipeline developments and significant R&D ...
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...
2 Reasons to Like JNJ and 1 to Stay Skeptical
Johnson & Johnson has been in a holding pattern, posting a small return of 0.7% while floating around $163.19.
Le Lézard1d
Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions
Scinai Immunotherapeutics Ltd. , a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and in providing CDMO services through its Scinai Bioservices unit, ...
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Siemens Healthineers AG (OtherSEMHF)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Johnson & Johnson (JNJ – Research ...
STAT2d
AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery
Imagine standing on a vast, dark plain. Without light, you cannot see dips and rolls in the grass or make out hills and ...
LUXTURNA Continues to Lead in Retinal Gene Therapy with Increased Market Penetration | DelveInsight
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...
Large pharma M&A deals stalling amid volatile policies, Reuters reports
Top health care investment bankers say that large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...
The Commonwealth Fund4d
How Potential Federal Cuts to Medicaid and SNAP Could Trigger the Loss of a Million-Plus Jobs, Reduced Economic Activity, and Less State Revenue
Combined losses from proposed cuts to Medicaid and SNAP would reach $1.1 trillion over a decade, including a $95 billion loss ...
News-Medical.Net4d
ELRIG announces Prof Rory Johnson and Dr Shalini Andersson as keynote speakers at therapeutic oligonucleotides 2025
ELRIG, a not-for-profit, volunteer-led organization for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...
GlobeSt4d
Johnson & Johnson Commits $55B to U.S. Healthcare Expansion
According to an announcement by the pharmaceutical company, Johnson & Johnson (JNJ) will invest over $55 billion in various ...